| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
May 25, 2018
DUBLIN - May 25, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the Jefferies 2018 Global Healthcare Conference on Wednesday, June...
-
May 24, 2018Onyx 1-Month OCT Study Provides Potential Insights on DAPT Duration in Complex Patients Following Stent Implantation
DUBLIN and PARIS- May 24, 2018 - Investigators today unveiled clinical data from the independently run Onyx 1-Month OCT Study, which showed strong early vessel healing in a patient population that...
-
May 24, 2018Q4 Revenue of $8.1 Billion Grew 2.9% Reported and 6.5% Organic
DUBLIN - May 24, 2018 - Medtronic plc (NYSE: MDT) today announced financial results for its fourth quarter and fiscal year 2018, which ended April 27, 2018. The company reported fourth quarter...
-
May 23, 2018Late-Breaking SPYRAL HTN-ON MED Study at EuroPCR Indicates RDN Lowers Blood Pressure in Hypertensive Patients in Presence of BP Medication
DUBLIN and PARIS - May 23, 2018 - Medtronic plc (NYSE:MDT) today announced first-ever-data from the SPYRAL HTN-ON MED Study. Initial study results found statistically significant and clinically...
-
May 18, 2018
DUBLIN - May 18, 2018 - Medtronic plc (NYSE:MDT) announced today that the company will host its biennial Institutional Investor and Analyst Meeting on Tuesday, June 5, 2018, in New York City from...
-
May 16, 2018Medtronic Received IDE Approval from FDA to Generate Clinical Evidence with Resolute Onyx DES to Support Future Application for Expanded Indication in U.S.
DUBLIN - May 16, 2018 - Medtronic plc (NYSE: MDT) today announced the initiation of a clinical study in the U.S. to assess the safety and efficacy of drug-eluting stents (DES) for the treatment of...
-
May 15, 2018Real-World Data on AdaptivCRT(TM) Algorithm Presented at Heart Rhythm 2018
DUBLIN - May 15, 2018 - Medtronic plc (NYSE: MDT) announced study results showing its exclusive AdaptivCRT(TM) algorithm is associated with improved patient survival. The data were recently...
-
May 11, 2018Late-Breaking Presentation at Heart Rhythm 2018 Highlights Investigational Experience with ICD Lead Placed Under Sternum, Outside the Heart and Veins
DUBLIN and BOSTON - May 11, 2018 - Medtronic plc (NYSE:MDT) today announced results from a research study demonstrating the feasibility of a novel approach to delivering pacing and defibrillation...
-
May 11, 2018Late-Breaking Presentation at Heart Rhythm 2018 Shows Potential for More Patients to Benefit from World's Smallest Pacemaker
DUBLIN and BOSTON - May 11, 2018 - Medtronic plc (NYSE:MDT) today announced new clinical study results demonstrating that an investigational algorithm, utilizing the accelerometer signal in the...
-
May 10, 2018
DUBLIN - May 10, 2018 - Medtronic plc (NYSE: MDT) announced today that it will report financial results for its fourth quarter and fiscal year 2018 on Thursday, May 24, 2018. A news release will...
-
May 9, 2018Results Presented at Heart Rhythm 2018 Also Show Leadless Pacemaker is Safe Option for Patients with Past Device Infection
DUBLIN and BOSTON - May 9, 2018 - Medtronic plc (NYSE: MDT) today announced that results through 12-months from the Post-Approval Registry (PAR) for the Medtronic Micra(TM) Transcatheter Pacing...
-
May 7, 2018
DUBLIN - May 7, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the appointment of Mike Weinstein as Senior Vice President, Strategy. In this role,...
-
May 2, 2018Integrated Technologies Allow a Fully Navigated Procedure with Fewer Surgical Steps
DUBLIN and NEW ORLEANS - May 2, 2018 - Medtronic plc (NYSE: MDT) today announced the advanced SynergyTLIFSM workflow - a procedural solution for spine surgery that combines innovative technologies...
-
May 1, 2018Medtronic Receives FDA Approval for Deep Brain Stimulation Therapy for Medically Refractory Epilepsy7-Year Data from the SANTE Trial Showed Median Seizure Frequency Reduction of 75 percent in Patients with Drug-Resistant Epilepsy with Partial-Onset Seizures Receiving DBS Therapy.
DUBLIN - May 1, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that the U.S. Food and Drug Administration (FDA) has granted premarket approval for Medtronic'
-
May 1, 2018
DUBLIN - May 1, 2018 - Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced expanded paid family leave benefits to allow for greater employee flexibility when...
-
May 1, 2018Medtronic Announces TiONIC(TM) Technology, a Titanium 3D Printed Platform for Spine Surgery ImplantsTechnology Allows for Creation of More Intricate Implant Designs and Surface Textures
DUBLIN and NEW ORLEANS - May 1, 2018 - Medtronic plc (NYSE: MDT) today announced the launch of a titanium 3D printed platform - TiONIC(TM) Technology - that enables more complex designs and...
-
Apr 30, 2018Approval Adds Two Additional Implants to Current Spine Labeling
DUBLIN - April 30, 2018 - Medtronic plc (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval of Infuse(TM) Bone Graft in new spine surgery indications. InfuseBone Graft is...
-
Apr 26, 2018
DUBLIN and SAN DIEGO - April 26, 2018 - Medtronic plc (NYSE: MDT) today announced two-year outcomes for the Harmony(TM) Transcatheter Pulmonary Valve (TPV) from its early feasibility study....
-
Apr 23, 2018New Indication Expands DCB Treatment for Patients with SFA Lesions Up to 360mm
DUBLIN - April 23, 2018 - Medtronic plc (NYSE: MDT) today announced that it has received U.S. Food and Drug Administration (FDA) approval for the IN.PACT(TM) Admiral(TM) Drug-Coated Balloon (DCB)...
-
Apr 17, 2018Product Line Offers Unique, Resorbable Option for Patients with Hypervascular Tumors
DUBLIN - April 17, 2018 - Medtronic plc (NYSE: MDT) today announced its U.S. launch of OptiSphere(TM) embolization spheres, a resorbable embolic platform designed for embolization of hypervascular...
-
Apr 10, 2018
DUBLIN - April 10, 2018 - Medtronic plc (NYSE: MDT) announced today the CE (Conformité Européenne) Mark and European launch of the Visualase(TM) MRI-Guided Laser Ablation System. The Visualase...
-
Apr 9, 2018Pivotal Trial Now Underway to Study Effect of Investigational Procedure in Patients with High Blood Pressure
DUBLIN - April 9, 2018 - Medtronic plc (NYSE:MDT) today announced U.S. Food and Drug Administration (FDA) approval to begin an investigational device exemption (IDE) pivotal trial to evaluate the...
-
Apr 9, 2018Data on Implant Approach, Blood Pressure Management, Length of Stay, and Quality of Life to be Featured During Congress.
DUBLIN - April 9, 2018 - Medtronic plc (NYSE: MDT) today announced a preview of notable clinical data on the HeartWare HVAD® System that will be presented at The International Society of Heart...
-
Apr 5, 2018
DUBLIN - April 5, 2018 - Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced Laura Mauri, M.D., M.Sc., interventional cardiologist and clinical researcher at the...
-
Mar 20, 2018Positive Data on Exclusive AdaptivCRT(TM) Feature Unveiled at EHRA Scientific Sessions 2018
DUBLIN and BARCELONA, Spain - March 20, 2018 - Two real-world analyses featuring the Medtronic plc (NYSE: MDT) AdaptivCRT(TM) algorithm reinforce that its use is linked to a reduction in atrial...